PeptideDB

SARS-CoV-2 3CLpro-IN-28

CAS: 2603242-35-7 F: C27H18Cl2N4O4 W: 533.36

SARS-CoV-2 3CLpro-IN-28 (Compound 19) is an inhibitor for SARS-CoV-2 3CLpro with an IC50 of 0.018 μM.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity SARS-CoV-2 3CLpro-IN-28 (Compound 19) is an inhibitor for SARS-CoV-2 3CLpro with an IC50 of 0.018 μM[1].
CAS 2603242-35-7
Formula C27H18Cl2N4O4
Molar Mass 533.36
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Banerjee S, et al., Exploring the key structural attributes and chemico-biological interactions of pyridinone-based SARS-CoV-2 3CLpro inhibitors through validated structure-based drug design strategies. Heliyon. 2024 Nov 15;10(23):e40404.